Oxford Nanopore Technologies responded to customer backlash by extending hardware and software support for its PromethIon 2 Solo (P2 Solo) sequencer through the end of 2030, two years longer than earlier plans. The company will stop selling the P2 Solo this summer but pledged continued compatibility and technical support to ensure established workflows can transition smoothly. The decision follows criticism from academic and lab customers who valued the P2 Solo’s affordability and local sequencing capability. Users warned that abrupt discontinuation could disrupt decentralized sequencing operations and slow research. Oxford Nanopore framed the change as customer‑driven and said the extended support window will provide time to plan transitions to its integrated platforms. The company’s move underscores the operational sensitivity of sequencing customers to product obsolescence timelines and the reputational risks of hardware sunsetting. Lab directors and procurement teams will now weigh transition costs, platform roadmaps and feature compatibility as they plan long‑term sequencing strategies.